id stringclasses 10 values | variant stringclasses 10 values | gene stringclasses 10 values | phenotype stringclasses 10 values | evidence_pack stringclasses 10 values | claim stringclasses 10 values | evidence_binding_map stringclasses 10 values | evidence_gaps stringclasses 10 values | claim_overreach_flags stringclasses 10 values | confidence_calibration stringclasses 10 values | notes stringclasses 10 values | constraints stringclasses 1 value | gold_checklist stringclasses 1 value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VEI-001 | c.1234A>G (p.Lys412Glu) | GENE1 | cardiomyopathy | Observed in 1 affected individual. Absent in 500 controls. No segregation. No functional assay. In silico: damaging. | Pathogenic variant causing cardiomyopathy. | Binding: case report and rarity only. In silico supports possible impact. | No segregation; no functional data; no replication; no population frequency context beyond small control set. | Pathogenic label overreach; causality overreach. | Low confidence. Classify as VUS with rationale. | Tests pathogenic overclaim | Under 220 words. | map+gaps+flags+calibration |
VEI-002 | rs999999 | GENE2 | type 2 diabetes | GWAS p=1e-9. OR 1.05. Non-coding region. Fine-mapping unresolved. No eQTL. No perturbation. | This variant causes diabetes. | Binding: association only with tiny effect size. | No causal mechanism; no functional perturbation; no linkage resolution. | GWAS treated as causal. | Very low confidence for causality. Association only. | GWAS causality error | Under 220 words. | map+gaps+flags+calibration |
VEI-003 | c.250del (frameshift) | GENE3 | neurodevelopmental delay | De novo in child. Parentage confirmed. LoF gene known haploinsufficient. Similar LoF reported in 12 cases. Functional: reduced protein. | Pathogenic and likely causal. | Binding: de novo + known LoF mechanism + replication + functional support. | Missing: detailed phenotype match; mosaicism check. | Minor. Evidence mostly adequate. | High confidence. Pathogenic. | Gold-standard case | Under 220 words. | map+gaps+flags+calibration |
VEI-004 | c.88C>T (p.Pro30Leu) | GENE4 | epilepsy | In silico: benign in 2 tools, damaging in 1. Seen at 0.5 percent in gnomAD. No case enrichment. No functional. | Likely pathogenic. | Binding: none supportive; population frequency argues against. | No case evidence; no function; frequency too high for rare epilepsy. | Likely pathogenic overreach. | Very low confidence. Likely benign or VUS. | In silico misuse plus frequency ignore | Under 220 words. | map+gaps+flags+calibration |
VEI-005 | chr7:12345 A>G | GENE5 | autoimmune phenotype | Cell line assay shows altered expression. No human genetic association. No segregation. | Causal variant for autoimmune disease. | Binding: functional in vitro only. | No human association; no in vivo model; no patient evidence. | Functional assay treated as disease proof. | Low confidence for disease causality. Functional effect only. | Function vs disease leap | Under 220 words. | map+gaps+flags+calibration |
VEI-006 | rs111111 | GENE6 | lipid levels | GWAS strong. eQTL links to gene expression in liver. CRISPR perturbation in hepatocytes shifts lipid pathway markers. | Causal regulatory variant affecting lipids. | Binding: association + eQTL + perturbation consistent with phenotype. | Missing: replication across ancestries; in vivo validation. | Moderate. Causality plausible but scope limited. | Moderate to high confidence for mechanism. Clinical impact uncertain. | Good causal chain but bounded | Under 220 words. | map+gaps+flags+calibration |
VEI-007 | c.500G>A (p.Arg167His) | GENE7 | rare syndrome | Reported in 2 papers but phenotypes differ. Variant also seen in gnomAD 0.1 percent. No functional. | This explains the syndrome. | Binding weak; phenotype mismatch and frequency conflict. | No consistent phenotype; no segregation; no function. | Overclaim; phenotype mismatch ignored. | Low confidence. VUS. | Phenotype drift | Under 220 words. | map+gaps+flags+calibration |
VEI-008 | c.900+1G>T (splice) | GENE8 | kidney disease | Splice site loss predicted. RNA shows exon skipping in patient tissue. Segregates in family. Multiple reports. | Pathogenic splice variant causing kidney disease. | Binding: predicted splice + RNA confirmation + segregation + replication. | Missing: penetrance estimate. | Minor. Penetrance uncertainty. | High confidence pathogenic. | Strong evidence binding | Under 220 words. | map+gaps+flags+calibration |
VEI-009 | polygenic_score | MULTI | CAD | PRS AUC 0.62 in one cohort. No external validation. Calibration unknown. | PRS proves genetic cause in this patient. | Binding: modest prediction only. | No individual-level causality; no calibration; no transportability test. | Prediction treated as proof. | Low confidence. Risk stratification only. | PRS misuse | Under 220 words. | map+gaps+flags+calibration |
VEI-010 | c.1201T>C (p.Ile401Thr) | GENE9 | cancer predisposition | Missense in tumor suppressor. Observed in tumor only. No germline test. No functional. | Germline pathogenic predisposition variant. | Binding: tumor-only observation. | No germline confirmation; no segregation; no function. | Somatic treated as germline. | Very low confidence. Needs germline testing. | Somatic vs germline boundary | Under 220 words. | map+gaps+flags+calibration |
What this dataset tests
Variant × evidence × claim.
Whether a genetic variant claim is grounded in real evidence.
Common error modes
- pathogenic label without functional evidence
- GWAS association treated as causality
- in silico prediction treated as proof
Required outputs
- evidence binding map
- evidence gaps
- claim overreach flags
- confidence calibration
Suggested prompt wrapper
System
You bind variant claims to evidence. You calibrate confidence to evidence strength.
User
Variant
{variant}
Evidence pack
{evidence_pack}
Claim
{claim}
Return
- evidence binding map
- evidence gaps
- claim overreach flags
- confidence calibration
Citation
ClarusC64 dataset family
- Downloads last month
- 24